Michael Schmidt

Michael Schmidt serves as CTO of DataRobot, where he is responsible for pioneering the next frontier of Augmented Intelligence and the company’s future cutting-edge technology. Schmidt joined DataRobot in 2017 following the company’s acquisition of Nutonian, a machine learning company he founded and led. Schmidt helped develop the Automated Time Series product, which launched in 2018 and most recently led DataRobot’s partnership with the U.S. government’s COVID-19 vaccine trials to ensure their speed and equity using AI.